SAN DIEGO, Aug. 12, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), have until September 28, 2026 to seek appointment as lead plaintiff of the Capicor class action lawsuit.  Captioned Nkamga v. Capricor Therapeutics, Inc., No. 26-cv-04385 (S.D. Cal.), the Capricor class action lawsuit charges Capricor as well as certain of Capricor's top executives with violations of the Securities Exchange Act of 1934.